Speeches & presentations

Search through our archive of speeches and presentations from conferences and events.

Filter by

  • David Redfern

    Investor Meeting at IAC, Washington

    ViiV Healthcare Chairman David Redfern, CEO Dominique Limet and Chief Scientific and Medical Officer, John Pottage, hosted an investor event at the International AIDS Conference (IAC).

  • Investor Meeting at ADA, Philadelphia

    Dr Carlo Russo, Senior Vice President and Head of Albiglutide Development hosted an investor event in conjunction with data presented at the American Diabetes Association meeting.

  • Investor Meeting at ASCO, Chicago

    Paolo Paoletti, President of GSK Oncology, hosted an investor event in conjunction with data presented at the American Society of Clinical Oncology (ASCO) meeting.

    Webcast
  • Deidre Connelly, Member of our Corporate Executive team, Talking

    World Affairs Council, Philadelphia

    Deirdre Connelly, President, North America Pharmaceuticals, gave a speech at the World Affairs Council (WAC) in Philadelphia about how the challenges and opportunities facing the pharmaceutical business.

  • R&D Seminar

    Moncef Slaoui, Chairman of Research & Development and Patrick Vallance, President, Pharmaceuticals R&D, presented a live webcast - Capital Allocation in R&D and a DPU Deep Dive.

  • Deidre Connelly, Member of our Corporate Executive team, Talking

    PharmEHR Summit, Philadelphia

    Deirdre Connelly, President, North America Pharmaceuticals, gave a speech at PharmEHR Summit in Philadelphia about how GSK sees healthcare evolving and how electronic health records fit into that shifting landscape.

  • Simon Dingemans, CFO, GSK

    Annual JP Morgan Healthcare Conference

    Simon Dingemans, Chief Financial Officer, gave a presentation at the 30th Annual JP Morgan Healthcare Conference in San Francisco.  Simon provided an overview of the progress being made in implementing GSK’s strategy.

  • simon dingemans

    Core Earnings Reporting

    Simon Dingemans, Chief Financial Officer discusses the methodology GSK will use for its core earnings reporting to begin with effect from Q1 2012.

  • Abbas Hussain

    Credit Suisse Healthcare Conference, Hong Kong

    Abbas Hussain, President, Emerging Markets & Asia Pacific gave a presentation at the Credit Suisse Asia Healthcare Conference in Hong Kong.  Abbas provided an overview of GSK's emerging markets strategy.

  • Bernstein Conference, New York

    Adrian Rawcliffe, SVP Finance North American Pharmaceuticals, presented at the Bernstein Pharma Conference: “Pharmaceutical R&D Productivity: Diagnosing the Problem & Searching for Solutions” in New York City. The conference was attended by over 100 investors. Ad discussed GSK’s R&D Strategy and its Focus on Return on Investment.

  • Citi’s Seminar in London on Vaccines in Emerging Markets

    Martin Andrews, SVP – Global Vaccines Centre of Excellence, GSK Biologicals, gave a presentation on GSK’s vaccines business at Citi’s Seminar in London on Vaccines in Emerging Markets.

  • Sir Andrew Witty

    Andrew Witty presents to the US State Department

    GSK CEO Andrew Witty presented at the United States Department of State symposium, “The Role of Innovation in Addressing Global Health”. In his address, which was convened to discuss advances and ways of working together to overcome diseases of the developing world, Andrew expanded upon GlaxoSmithKline’s commitments in this area.

  • Abbas Hussain

    Presentation to investors

    Abbas Hussain, President, Emerging Markets, gave a presentation to a small group of investors, where he provided an overview of GSK's emerging markets strategy.

  • Dr Patrick Vallance

    Cowen and Company 31st Annual Health Care Conference

    Patrick Vallance, SVP – Medicines Discovery and Development, gave a presentation at the Cowen and Company 31st Annual Health Care Conference in Boston. Patrick provided an overview of GSK’s R&D Strategy and its Focus on Return on Investment.

  • Deidre Connelly, Member of our Corporate Executive team, Talking

    CED Biotech/Life Science Conference

    Deirdre Connelly, President, North American Pharmaceuticals, addressed the CED Biotech/Life Science Conference in Raleigh, Durham, on 21 February 2011.

  • David Redfern

    The Economist Pharma Summit

    David Redfern, GSK Chief Strategy Officer, was one of the two keynote speakers at The Economist Pharma Summit Reinventing Pharma for a New Generation  on 10 February 2011 in London. He outlined GSK’s strategic priorities, our innovative approach to pricing and the value of our late stage pipeline coupled with our ongoing efforts to drive the effectiveness of R&D.

  • Deidre Connelly, Member of our Corporate Executive team, Talking

    CBI 8th Annual Pharmaceutical Compliance Conference

    Deirdre Connelly, President, North American Pharmaceuticals, addressed the 8th annual Center for Business Intelligence (CBI) pharmaceutical compliance conference on 24 January. Deirdre spoke about what the pharmaceutical industry must do to build trust.

  • David Redfern

    JP Morgan Healthcare Conference

    David Redfern, Chief Strategy Officer at GlaxoSmithKline, gave a presentation at the 29th Annual JP Morgan Healthcare Conference in San Francisco.  David provided an overview of the progress being made in implementing GSK’s strategy.

  • Sir Andrew Witty

    CEO Andrew Witty discusses R&D and drug discovery on BBC Radio 4

    CEO Andrew Witty discusses R&D and drug discovery on BBC Radio 4.

     

    Webcast
  • Eddie Gray, President GSK Pharma Europe, speaks at FT pharmaceutical conference

    The 27th annual FT Global Pharmaceutical & Biotechnology Conference took place in London on 1–2 December 2010. The event brought together thought-leaders from the pharmaceutical industry, patient groups, regulators, health technology assessment (HTA) groups to share insights and discuss the future for healthcare and the role of the pharmaceutical industry.